Fractyl Health (GUTS) announced the pricing of an underwritten offering of 60 million shares of its common stock at a price of $1.00 per share. All of the securities are being offered by Fractyl. The gross proceeds from the offering to Fractyl are expected to be approximately $60 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about September 29, 2025, subject to customary closing conditions. BofA Securities and Evercore ISI are acting as joint book-running managers and Ladenburg Thalmann is acting as lead manager for the underwritten offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GUTS:
- Fractyl Health announces REMAIN-1 study met 3-month efficacy endpoint
- Fractyl Health initiated with a Buy at H.C. Wainwright
- Fractyl Health Appoints New Directors Amid Leadership Changes
- Fractyl Health appoints Christopher Thompson, Ian Sheffield to board
- Fractyl Health initiated with a Buy at Ladenburg